p16^<INK4> Expression Is Associated with the Increased Sensitivity of Human Non-small Cell Lung Cancer Cells to DNA Topoisomerase I Inhibitors
スポンサーリンク
概要
- 論文の詳細を見る
- 1997-10-31
著者
-
Kaniwa N
Department Of Genome Biology Kinki University School Of Medicine
-
Saijo N
Division Of Internal Medicine National Cancer Center Hospital East
-
Saijo Nagahiro
国立医薬品食品衛生研究所
-
Saijo N
Medical Oncology National Cancer Center Hospital
-
YOKOTA Jun
Biology Division, National Cancer Center Research Institute
-
NISHIO Kazuto
Department of Genome Biology, Kinki University School of Medicine
-
Nishio K
Department Of Genome Biology Kinki University School Of Medicine
-
Kuzuya Nobuaki
国立医薬食品衛生研究所 薬物応答予測プロジェクト
-
YOKOTE Hideyuki
Shien-Laboratory, National Cancer Center Hospital
-
NISHIO Kazuto
Pharmacology Division, National Cancer Center Research Institute
-
ARIOKA Hitoshi
Pharmacology Division, National Cancer Center Research Institute
-
ISHIDA Tomoyuki
Pharmacology Division, National Cancer Center Research Institute
-
FUKUMOTO Hisao
Pharmacology Division, National Cancer Center Research Institute
-
FUKUOKA Kazuya
Pharmacology Division, National Cancer Center Research Institute
-
NOMOTO Taisuke
Pharmacology Division, National Cancer Center Research Institute
-
KUROKAWA Hirokazu
Pharmacology Division, National Cancer Center Research Institute
-
YOKOTE Hideyuki
Pharmacology Division, National Cancer Center Research Institute
-
Saijo Nagahiro
Pharmacology Division, National Cancer Center Research Institute
-
ADACHI Jun-ichi
Biology Division, National Cancer Center Research Institute
-
TOMONARI Akira
Pharmacology Division, National Cancer Center Research Institute
-
NARITA Nobuhiro
Second Department of Internal Medicine, Nara Medical University
-
Fukumoto H
National Cancer Center Res. Inst.
-
Fukumoto Hisao
国立がんセンター
-
Fukumoto Hisao
Pharmacology Division Natonal Cancer Center Research Instiute
-
Fukumoto Hisao
Pharmacology Division National Cancer Center Research Institute
-
Tomonari Akira
Pharmacology Division National Cancer Center Research Institute
-
Kanzawa Fumihiko
国立がんセンター
-
Kanzawa Fumihiko
Pharmacology:pathology Division National Cancer Center Research Institute:surgery Division:departmen
-
Ishida Tomoyuki
Pharmacology Division National Cancer Center Research Institute
-
Ishida Tomoyuki
国立がんセンター
-
Arioka H
National Cancer Center Res. Inst.
-
Arioka Hiroshi
国立がんセンター
-
Arioka Hitoshi
国立がんセンター中央病院
-
Arioka Hitoshi
Pharmacology Division National Cancer Center Research Institute
-
Fukuoka K
National Cancer Center Res. Inst.
-
Kurokawa Hirokazu
Pharmacology Division National Cancer Center Research Institute
-
Kurokawa Hirokazu
国立がんセンター
-
Nomoto T
Pharmacology Division National Cancer Center Research Institute
-
Nomoto Taisuke
国立がんセンター
-
Nomoto Taisuke
Pharmacology Division National Cancer Center Research Institute
-
Yokote Hideyuki
近畿大学 医学部ゲノム生物学
-
Yokote H
Shien-laboratory National Cancer Center Hospital
-
Yokote Hideyuki
Department Of Genome Biology Kinki University School Of Medicine
-
Yokote Hideyuki
Pharmacology Division National Cancer Center Research Institute
-
Nishio Kazuto
Pharmacology Division National Cancer Center Research Institute
-
Saijo Nagahiro
Department Of Internal Medicine National Cancer Center Hospital
-
Saijo Nagahiro
Pharmacology Division National Cancer Center Research Institute
-
Adachi J
Biology Division National Cancer Center Research Institute
-
Yokota J
National Cancer Center Res. Inst. Tokyo
-
Yokota Jun
Biology Division National Cancer Center Research Institute
-
Narita N
Shibaura Inst. Of Technol. Tokyo
-
Narita Nobuhiro
Second Department Of Internal Medicine Nara Medical University
-
Fukuoka Kazuya
Pharmacology Division National Cancer Center Research Institute
関連論文
- Genetic Variations and Haplotypes of ABCC2 Encoding MRP2 in a Japanese Population
- Genetic variations and haplotype structures of the DPYD gene encoding dihydropyrimidine dehydrogenase in Japanese and their ethnic differences
- Genetic Variations of the ABC Transporter Gene ABCB11 Encoding the Human Bile Salt Export Pump (BSEP) in a Japanese Population
- Twelve Novel Single Nucleotide Polymorphisms in the CES2 Gene Encoding Human Carboxylesterase 2 (hCE-2)
- 日本人におけるGSTT1及びGSTM1の遺伝子多型の同定及びハプロタイプ構造の解析
- Twenty Novel Genetic Variations and Haplotype Structures of the DCK Gene Encoding Human Deoxycytidine Kinase (dCK)
- Genetic Variations of VDR/NR1I1 Encoding Vitamin D Receptor in a Japanese Population
- Genetic Variations and Frequencies of Major Haplotypes in SLCO1B1 Encoding the Transporter OATP1B1 in Japanese Subjects : SLCO1B1^*17 is More Prevalent Than ^*15
- Genetic Variations and Haplotype Structures of the ABC Transporter Gene ABCC1 in a Japanese Population
- Fourteen Novel Genetic Variations and Haplotype Structures of the TYMS Gene Encoding Human Thymidylate Synthase (TS)
- 日本人における Denaturing HPLC を用いた Thiopurine S-Methyltransferase 遺伝子の新規SNPスクリーニング
- 日本人におけるヒトSLC29A1の新規遺伝子多型の同定
- Genetic Variation and Haplotype Structure of the ABC Transporter Gene ABCG2 in a Japanese Population
- Genetic Variations and Haplotypes of UGT1A4 in a Japanese Population
- Genetic Polymorphisms of UGT1A6 in a Japanese Population
- Single Nucleotide Polymorphisms and Haplotypes of CYP1A2 in a Japanese Population
- Genetic Variations of the AHR Gene Encoding Aryl Hydrocarbon Receptor in a Japanese Population
- Non-synonymous Single Nucleotide Alterations Found in the CYP2C8 Gene Result in Reduced in Vitro Paclitaxel Metabolism
- Expression of CYP2A6 in Tumor Cells Augments Cellular Sensitivity to Tegafur
- Three Novel Single Nucleotide Polymorphisms in UGT1A9
- Novel Genetic Polymorphisms in the NR3C1 (Glucocorticoid receptor) Gene in a Japanese Population
- Twenty-six Novel Single Nucleotide Polymorphisms and their Frequencies of the NR113 (CAR) Gene in a Japanese Population
- Eight Novel Single Nucleotide Polymorphisms in ABCG2/BCRP in Japanese Cancer Patients Administered Irinotacan
- Three novel single nucleotide polymorphisms in UGT1A10
- Association of the OGG1-Ser326Cys polymorphism with lung adenocarcinoma risk
- Identification of prognostic biomarkers in gastric cancer using endoscopic biopsy samples
- Establishment and molecular profiling of a novel human pancreatic cancer panel for 5-FU
- Antibody-dependent cellular cytotoxicity of cetuximab against tumor cells with wild-type or mutant epidermal growth factor receptor
- Synergistic interactions between the synthetic retinoid tamibarotene and glucocorticoids in human myeloma cells
- A literature review of molecular markers predictive of clinical response to cytotoxic chemotherapy in patients with breast cancer
- Pertuzumab, a novel HER dimerization inhibitor, inhibits the growth of human lung cancer cells mediated by the HER3 signaling pathway
- Anticancer effects of ZD6474, a VEGF receptor tyrosine kinase inhibitor, in gefitinib ("Iressa")-sensitive and resistant xenograft models
- Antitumor activity of TZT-1027 (Soblidotin) against vascular endothelial growth factor-secreting human lung cancer in vivo
- Reversal of Cisplatin Resistance by the 1,4-Benzothiazepine Derivative, JTV-519
- CPT-11 Alters the Circadian Rhythm of Dihydropyrimidine Dehydrogenase mRNA in Mouse Liver
- Enhancement of Cisplatin Sensitivity in High Mobility Group 2 cDNA-transfected Human Lung Cancer Cells
- Characterization of a Human Small-cell Lung Cancer Cell Line Resistant to a New Water-soluble Camptothecin Derivative, DX-8951f
- Preferential Binding of E7010 to Murine β3-Tubulin and Decreased β3-Tubulin in E7010-resistant Cell Lines
- In vitro Enhancement of Antitumor Activity of a Water-soluble Duocarmycin Derivative, KW-2189, by Caffeine-mediated DNA-repair Inhibition in Human Lung Cancer Cells
- p16^ Expression Is Associated with the Increased Sensitivity of Human Non-small Cell Lung Cancer Cells to DNA Topoisomerase I Inhibitors
- Interferon-γ-inducing Factor Gene Transfection into Lewis Lung Carcinoma Cells Reduces Tumorigenicity in vivo
- Effect of Glutathione Depletion on Cisplatin Resistance in Cancer Cells Transfected with the γ-Glutamylcysteine Synthetase Gene
- A Topoisomerase II Inhibitor, NK109, Induces DNA Single- and Double-strand Breaks and Apoptosis
- Effect of suramin on cdc2 kinase activity of the purified enzyme and from the crude extracts from lung cancer cells
- Correlation of Gene-specific Damage with Cisplatin between Human Adenocarcinoma Cells and Peripheral Blood Mononuclear Cells Analyzed by Polymerase Chain Reaction-stop Assay
- Development and characterization of an antibody specifically recognizing a mutant EGFR (L858R) protein expressed frequently in non-small cell lung cancer
- S2-4 ヒトがん細胞におけるがん抑制遺伝子失活の分子機構シンポジウム(2)「細胞がん化のブラックボックスに挑む」)
- High sensitivity detection of epidermal growth factor receptor mutations in the pleural effusion of non-small cell lung cancer patients
- A Limited Sampling Model for Estimating Pharmacokinetics of CPT-11 and Its Metabolite SN-38
- 日本人におけるABCC3遺伝子の多型解析
- Enhancement of in vivo Antitumor Activity of a Novel Antimitotic 1-Phenylpropenone Derivative, AM-132, by Tumor Necrosis Factor-α or Interleukin-6
- Intracellular Carboxyl Esterase Activity Is a Determinant of Cellular Sensitivity to the Antineoplastic Agent KW-2189 in Cell Lines Resistant to Cisplatin and CPT-11
- Analysis of Cisplatin Behavior in a Non-Small Cell Lung Cancer (NSCLC) Cell Line
- Infrequent Mutations of the hOGG1 Gene, That Is Involved in the Excision of 8-Hydroxyguanine in Damaged DNA, in Human Gastric Cancer
- Germline Mutations of the PTEN/MMAC1 Gene in Japanese Patients with Cowden Disease
- Molecular footprints of human lung cancer progression
- ANTITUMOR ACTIVITY OF ALKYLESTERS OF 5-FLUORO-2'-DEOXYURIDINE 5'-MONOPHOSPHATE (FDUMP) AGAINST MURINE LYMPHOMA L5178Y RESISTANT TO 5-FLUORO-2'-DEOXYURIDINE
- Immunotherapy by intra-peritoneal intra-peritoneal injection of interleukin-2 gene transduced ling cancer cell line.
- Loss of heterozygosity at a cellular senescence locus on human chromosome 2 in various types of tumors
- Effect of the introduction of minimum lesion size on interobserver reproducibility using RECIST guidelines in non-small cell lung cancer patients
- What is the most informative pharmacodynamic model for paclitaxel (T)? : a 3 hour-infusion vs. 24-hour infusion.
- Association of epidermal growth factor receptor (EGFR) gene mutations with EGFR amplification in advanced non-small cell lung cancer
- Problems with Registration-Directed Clinical Trials for Lung Cancer in Japan
- Phase I study of cisplatin, vinorelbine, and concurrent thoracic radiotherapy for unresectable stage III non-small cell lung cancer
- Tumor response to chemotherapy : The validity and reproducibility of RECIST guidelines in NSCLC patients
- INHIBITORY EFFECTS OF REPEATED INTRAVENOUS INJECTIONS OF DEXAMETHASONE ON PULMONARY TOXICITY OF A NEW MITOMYCIN C ANALOGUE, KW-2149, IN A NOVEL RAT MODEL
- Inhibitory effects of dexamethasone on pulmonary toxicity of a new mitomycin C analogue KW-2149 in a novel rat model.
- Prospective Evaluation of the Feasibility of Cisplatin-based Chemotherapy for Elderly Lung Cancer Patients with Normal Organ Functions
- Detection of Three Genetic Polymorphisms in the 5'-Flanking Region and Intron 1 of Human CYP1A2 in the Japanese Population
- ANTITUMOR ACTIVITY OF QUINOCARMYCIN AGAINST CARCINOMA OF THE LUNG IN HUMAN TUMOR CLONOGENIC ASSAY
- N-Glycan fucosylation of epidermal growth factor receptor modulates receptor activity and sensitivity to epidermal growth factor receptor tyrosine kinase inhibitor
- Deficiency of antiproliferative family protein Ana correlates with development of lung adenocarcinoma
- Enhanced Anti-tumor Effect of Trastuzumab in Combination with Cisplatin
- Long-term follow-up of patients with unresectable locally advanced non-small cell lung cancer treated with chemoradiotherapy: A retrospective analysis of the data from the Japan Clinical Oncology Group trials (JCOG0003A)
- Phase I Study of Paclitaxel by Three-hour Infusion : Hypotension Just after Infusion Is One of the Major Dose-limiting Toxicities
- Antitumor activity of cetuximab against malignant glioma cells overexpressing EGFR deletion mutant variant III
- Progress in the field of molecular biology and application of biotechnology to medical oncology
- Epidermal growth factor receptor lacking C-terminal autophosphorylation sites retains signal transduction and high sensitivity to epidermal growth factor receptor tyrosine kinase inhibitor
- Poly(ADP-ribose) polymerase-1 gene in human tumor cell lines: Its expression and structural alteration
- Clinical evaluation of ^Tc-Technegas SPECT in thoracoscopic lung volume reduction surgery in patients with pulmonary emphysema
- COMPARATIVE STUDIES OF PULSE AND CONTINUOUS EXPOSURE IN HUMAN TUMOR CLONOGENIC ASSAY
- THE USE OF HUMAN TUMOR CLONOGENIC ASSAY IN PREDICTING COMBINATION EFFECT OF CISPLATIN PLUS VINDESINE IN CARCINOMA OF THE LUNG
- Effects of Src inhibitors on cell growth and epidermal growth factor receptor and MET signaling in gefitinib-resistant non-small cell lung cancer cells with acquired MET amplification
- Genetic Polymorphisms of Copper- and Platinum Drug-efflux Transporters ATP7A and ATP7B in Japanese Cancer Patients
- Ethnic Differences of two Non-synonymous Single Nucleotide Polymorphisms in CDA Gene
- Translational and clinical studies of target-based cancer therapy
- Absence of Germline CHK2 Mutations in Familial Gastric Cancer
- A Computational Model for Quantitative Analysis of Cell Cycle Arrest and Its Contribution to Overall Growth Inhibition by Anticancer Agents
- IN VITRO CHEMOSENSITIVITY PATTERNS OF CARCINOMA OF THE LUNG IN HUMAN TUMOR CLONOGENIC ASSAY
- Bortezomib potentially inhibits cellular growth of vascular endothelial cells through suppression of G2/M transition
- 384 Development of Resistance to Anticancer Drugs in NIH3T3 Cells Transfected with c-myc and/or c-H-ras Genes.
- A Pharmacokinetic and Pharmacodynamic Analysis of CPT-11 and Its Active Metabolite SN-38
- Prediction of Severe Adverse Drug Reactions Using Pharmacogenetic Biomarkers
- Genetic Polymorphisms of FCGRT Encoding FcRn in a Japanese Population and Their Functional Analysis
- Role of ZNF143 in tumor growth through transcriptional regulation of DNA replication and cell-cycle-associated genes
- Plasma concentrations of VCAM-1 and PAI-1 : A predictive biomarker for post-operative recurrence in colorectal cancer
- Stochastic Properties of Prescriptions for Infectious and Non-Infectious Diseases Dispensed by a City Pharmacy
- Enhanced expression of nuclear factor I/B in oxaliplatin-resistant human cancer cell lines
- Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2010 for the treatment of colorectal cancer